|
April 8, 2021
|
Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2 Clinical Trial in Moderate-to-Severe Atopic Dermatitis
|
|
|
March 23, 2021
|
Connect Biopharma Holdings Limited Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
|
|
|
March 18, 2021
|
Connect Biopharma Holdings Limited announces pricing of Initial Public Offering
|
|
|
January 26, 2021
|
Connect Biopharma Strengthens Leadership Team with Key Hire
|
|
|
January 5, 2021
|
Connect Biopharma Establishes Scientific Advisory Board Comprised of Clinical Development and Program Indication Experts
|
|
